| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 05/02/2002 | EP1202065A1 Net, a transcription factor of the TCF family, as regulator of angiogenic expression. |
| 05/02/2002 | EP1201661A1 Heteroaromatic ring compounds |
| 05/02/2002 | EP1201660A1 Glucocorticoid receptor modulators |
| 05/02/2002 | EP1201649A1 Glucocorticoid receptor modulators |
| 05/02/2002 | EP1201241A2 Compositions containing capsaicin or capsaicin analogues and a local anesthetic |
| 05/02/2002 | EP1201240A2 Heterocyclic derivatives useful as pharmaceutical agents |
| 05/02/2002 | EP1201239A1 Cyclic amine ccr3 antagonists |
| 05/02/2002 | EP1201238A1 Sulfonamide derivatives and remedies for allodynia |
| 05/02/2002 | EP1201230A2 Solution-based transdermal drug delivery system comprising a vasodilator |
| 05/02/2002 | EP1201227A2 Use of flavonoids as immunomodulating or immunoprotecting agents in cosmetic and dermatological compositions |
| 05/02/2002 | EP1201136A1 Food grade transglutaminase inhibitor and uses thereof |
| 05/02/2002 | EP1200596A2 Human synthetases |
| 05/02/2002 | EP1200595A2 Myxoma virus genes for immune modulation |
| 05/02/2002 | EP1200593A2 The il-1l1 gene and polypeptide products |
| 05/02/2002 | EP1200586A2 Human nervous system-associated proteins |
| 05/02/2002 | EP1200584A1 Splice variants of cd40-receptor |
| 05/02/2002 | EP1200582A2 Human proteins having hydrophobic domains and dnas encoding these proteins |
| 05/02/2002 | EP1200570A1 Antisense modulation of p13 kinase p110 delta expression |
| 05/02/2002 | EP1200560A1 Melanin-concentrating hormone receptor |
| 05/02/2002 | EP1200462A2 Use of quinic, shikimic acids and their derivatives for preparing mannose receptor ligands |
| 05/02/2002 | EP1200435A1 Purine derivatives inhibitors of tyrosine protein kinase syk |
| 05/02/2002 | EP1200422A2 Pyrazole compositions useful as inhibitors of erk |
| 05/02/2002 | EP1200419A1 Aminothiazole derivatives and their use as crf receptor ligands |
| 05/02/2002 | EP1200402A1 Substituted 1,5-dihydropyrrol-2-on derivatives as nmda receptor antagonists for the treatment of pain |
| 05/02/2002 | EP1200400A1 Substituted pyrrolidin-2,3,4-trion-3-oxime derivatives useful as nmda-receptor antagonists |
| 05/02/2002 | EP1200398A1 3-arylsulfonyl-2-(substituted methyl)propanoic acid derivates as matrix metalloproteinase inhibitors |
| 05/02/2002 | EP1200320A1 Valve with a two-component seal |
| 05/02/2002 | EP1200151A1 Drug delivery device for insertion into the vagina, rectum or nasal cavity |
| 05/02/2002 | EP1200140A1 Controlled release implantable devices |
| 05/02/2002 | EP1200127A2 Solutions and methods for inhibition of pain, inflammation and cartilage degradation |
| 05/02/2002 | EP1200114A2 Ppar delta inhibitors for the treatment of cardiovascular diseases |
| 05/02/2002 | EP1200106A1 Composition containing extracts of butyrospermum parkii and the use as medicament or dietary supplement |
| 05/02/2002 | EP1200096A1 Tixocortol pivalate suspension, mouth-wash based thereon and packaging containing same |
| 05/02/2002 | EP1200094A1 Ophthalmic compositions containing antibiotics and nsaids |
| 05/02/2002 | EP1200088A2 Paracetamol and drotaverine containing composition |
| 05/02/2002 | EP1200086A2 Methods for treating or preventing pain and anxiety |
| 05/02/2002 | EP1200085A1 Pharmaceutical and nutritional compositions containing essential fatty acids and homocysteine-lowering agents |
| 05/02/2002 | EP1200076A1 Calcilytic compounds |
| 05/02/2002 | EP1200066A1 Aqueous nasal formulation |
| 05/02/2002 | EP1200064A1 Delivery system for oral care compositions comprising organosiloxane reins using a removable backing strip |
| 05/02/2002 | EP1146875A4 Myt1 kinase inhibitors |
| 05/02/2002 | EP0931086B1 Tetrahydronaphthalene derivatives and their therapeutic use |
| 05/02/2002 | EP0746567B1 Novel opioid peptides for the treatment of pain and use thereof |
| 05/02/2002 | EP0593585B1 Peptide which abrogates tnf and lps toxicity |
| 05/02/2002 | DE10052658A1 Neue Pyranosidderivate New Pyranosidderivate |
| 05/02/2002 | DE10049549A1 Inhibitor of the transcription factor IFR-1, useful for treating e.g. transplant rejection and autoimmune disease, reduces expression of CD40 |
| 05/02/2002 | DE10049483A1 Substituierte 1-Aminobutan-3-ol-Derivate Substituted 1-aminobutan-3-ol derivatives |
| 05/02/2002 | DE10049481A1 Substituierte C-Cyclohexylmethylamin-Derivate C-substituted derivatives cyclohexylmethylamine |
| 05/02/2002 | CA2689012A1 Method for the treatment of neurological and neuropsychological disorders |
| 05/02/2002 | CA2678256A1 Methods of treating vascular diseases characterized by nitric oxide insufficiency |
| 05/02/2002 | CA2427085A1 Transmembrane proteins |
| 05/02/2002 | CA2427024A1 Methods for screening compounds that modulate lipid metabolism |
| 05/02/2002 | CA2427005A1 Multi-component antioxidant compounds, pharmaceutical compositions containing same and their use for reducing or preventing oxidative stress |
| 05/02/2002 | CA2426736A1 Vegf peptides and their use for inhibiting angiogenesis |
| 05/02/2002 | CA2426564A1 Pyranoside derivatives |
| 05/02/2002 | CA2426294A1 Nucleic acid generating the abca7 gene, molecules modulating its activity and therapeutic applications |
| 05/02/2002 | CA2426244A1 Lipid formulations for target delivery |
| 05/02/2002 | CA2425288A1 Pyrrolidine modulators of ccr5 chemokine receptor activity |
| 05/02/2002 | CA2425283A1 Spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors |
| 05/02/2002 | CA2425280A1 Pyrimidine-2,4,6-trione metalloproteinase inhibitors |
| 05/02/2002 | CA2424475A1 Method for the treatment of neurological and neuropsychological disorders |
| 05/02/2002 | CA2422787A1 C-nitroso compounds and use thereof |
| 05/02/2002 | CA2421885A1 Methods of treating vascular diseases characterized by nitric oxide insufficiency |
| 05/01/2002 | CN1347419A Pyrrolidincarbonylamino cyclic disulfides |
| 05/01/2002 | CN1347411A Sulfonamide derivs. having oxadiazole rings |
| 05/01/2002 | CN1347408A Use of maduraphthalazine derivs. as inhibitors of pro-inflammatory cytokins |
| 05/01/2002 | CN1347404A (-)-Verbenzone derivs. |
| 05/01/2002 | CN1347398A Salts of asiatic and madecassic acid suitable for preparation of pharmaceutical and cosmetic compositions |
| 05/01/2002 | CN1347326A BAFF, inhibitors thereof and their use in modulation of B-cell response |
| 05/01/2002 | CN1347323A Chemical compounds |
| 05/01/2002 | CN1347322A Chemical compounds |
| 05/01/2002 | CN1347318A Inhibitors of IMPDH enzyme |
| 05/01/2002 | CN1347309A Skin care compositions contg. combination of skin care actives |
| 05/01/2002 | CN1347308A Skin care compositions contg. combination of skin care actives |
| 05/01/2002 | CN1346828A Dicyclic aromatic compound and use thereof in human or animal medicine and cosmetic process |
| 05/01/2002 | CN1346666A Chinese patent medicine for treating chronic colitis |
| 05/01/2002 | CN1083842C [1,2,4] triazolo [4,3-a] quinoxalinone derivs., their preparation and use |
| 05/01/2002 | CN1083830C Substd. benzamidines, their production and their use as medicaments |
| 04/30/2002 | US6380396 Chemical intermediates for antiinflammatory agents |
| 04/30/2002 | US6380258 Sulfonyl divalent aryl or heteroaryl hydroxamic acid compounds |
| 04/30/2002 | US6380255 Treatment for dermal skin atrophy using thyroid hormone compounds or thyroid hormone-like compounds |
| 04/30/2002 | US6380223 For therapy of diseases, such as obesity, diabetes, inflammation |
| 04/30/2002 | US6380218 For therapy of respiratory, allergic, and inflammatory disorders comprising asthma, chronic obstructive pulmonary disease, acute respiratory disease syndrome, pulmonary hypersensitivity, and allergic rhinitis in a mammal |
| 04/30/2002 | US6380207 1h-(1)benzopyrano(3,4-f) quinoline derivatives |
| 04/30/2002 | US6380170 Nucleic acid construct for the cell cycle regulated expression of structural genes |
| 04/30/2002 | US6380162 Ice inhibiting peptides |
| 04/30/2002 | US6379926 Polynucleotides encoding chemokine β-6 antagonists |
| 04/30/2002 | CA2358678A1 Heterocyclic derivatives useful as pharmaceutical agents |
| 04/30/2002 | CA2241827C Novel substituted 4-(1h-benzimidazol-2-yl)¬1,4|diazepanes useful for the treatment of allergic diseases |
| 04/30/2002 | CA2200771C New silicated salicylic acid derivatives with desquamative properties |
| 04/30/2002 | CA2151045C Platelet-activating factor acetylhydrolase |
| 04/25/2002 | WO2002033101A1 Chimeric cytoplasmic signalling molecules derived from cd137 |
| 04/25/2002 | WO2002033099A2 Human kinases |
| 04/25/2002 | WO2002033085A2 Wisp polypeptides and therapeutical applications thereof |
| 04/25/2002 | WO2002033049A1 Human tuberoinfundibular peptide of 39 residues |
| 04/25/2002 | WO2002032953A2 Pregnancy-associated plasma protein-a2 (papp-a2) |
| 04/25/2002 | WO2002032901A2 Bridged piperazine derivatives |
| 04/25/2002 | WO2002032900A2 Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents |
| 04/25/2002 | WO2002032894A1 Substituted imidazoles useful in the treatment of inflammatory diseases |
| 04/25/2002 | WO2002032879A1 Dihydropyrimidine derivatives as cysteine protease inhibitors |